Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-07

FDA Approved: DOCOSANOL — Original Application (H2-Pharma, LLC)

View source ↗

Summary

FDA approved an Original Application for docosanol filed by H2-Pharma, LLC, granting a generic approval for topical treatment of herpes simplex virus infections…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Docosanol (docosanol)

Snippet

ORIG AP for DOCOSANOL (DOCOSANOL)